Increased levels of NfL have been identified in CSF and plasma from individuals with HD compared with control subjects [167,168,169,170], and this correlates with clinical measures of dysfunction and brain atrophy [168,169,170]. The gene discussed is NEFL; the disease is Huntington disease.